BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12109057)

  • 1. [Adverse chemotherapy effects on skin and mucous membranes].
    Trojan A; Borelli S
    Praxis (Bern 1994); 2002 Jun; 91(24):1078-87. PubMed ID: 12109057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucocutaneous side effects of antineoplastic chemotherapy.
    Guillot B; Bessis D; Dereure O
    Expert Opin Drug Saf; 2004 Nov; 3(6):579-87. PubMed ID: 15500416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pigmentary disorders induced by anticancer agents. part I: chemotherapy].
    Sibaud V; Fricain JC; Baran R; Robert C
    Ann Dermatol Venereol; 2013 Mar; 140(3):183-96. PubMed ID: 23466151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous adverse effects of targeted therapies: Part I: Inhibitors of the cellular membrane.
    Macdonald JB; Macdonald B; Golitz LE; LoRusso P; Sekulic A
    J Am Acad Dermatol; 2015 Feb; 72(2):203-18; quiz 219-20. PubMed ID: 25592338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
    Eich D; Scharffetter-Kochanek K; Eich HT; Tantcheva-Poor I; Krieg T
    Am J Clin Oncol; 2002 Dec; 25(6):599-602. PubMed ID: 12478008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy.
    Prussick R
    Semin Cutan Med Surg; 1996 Dec; 15(4):267-76. PubMed ID: 9069595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous drug eruptions associated with the use of new oncological drugs.
    Belloni B; Schönewolf N; Rozati S; Goldinger SM; Dummer R
    Chem Immunol Allergy; 2012; 97():191-202. PubMed ID: 22613863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Side-effects of cytostatic agents].
    Mayr AC; Nagel GA; Dick HJ; Obrecht JP
    Schweiz Med Wochenschr; 1973 Sep; 103(36):1252-5. PubMed ID: 4270669
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy and cutaneous toxicities: implications for oncology nurses.
    Viale PH
    Semin Oncol Nurs; 2006 Aug; 22(3):144-51. PubMed ID: 16893743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucocutaneous side effects of Brequinar sodium. A new inhibitor of pyrimidine de novo biosynthesis.
    Schwartsmann G; Bork E; Vermorken JB; Nieboer C; Dodion P; ten Bokkel Huinink WW; Seldenrijk CA; Armand JP; Pinedo HM
    Cancer; 1989 Jan; 63(2):243-8. PubMed ID: 2521297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Management of Cutaneous Adverse Events in Patients on Chemotherapy: A National Consensus Statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology.
    Sanmartín O; Beato C; Suh-Oh HJ; Aragón I; España A; Majem M; Segura S; Gúrpide A; Botella R; Grávalos C
    Actas Dermosifiliogr (Engl Ed); 2019; 110(6):448-459. PubMed ID: 31010573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophilic eccrine hidradenitis: a case report and review of the literature.
    Margolis DJ; Gross PR
    Cutis; 1991 Sep; 48(3):198-200. PubMed ID: 1834438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cutaneous side effects of antitumor chemotherapy].
    Delaunay M
    Ann Dermatol Venereol; 1989; 116(4):347-61. PubMed ID: 2528934
    [No Abstract]   [Full Text] [Related]  

  • 14. Skin toxicity of anti-cancer therapy.
    Ulrich J; Hartmann JT; Dörr W; Ugurel S
    J Dtsch Dermatol Ges; 2008 Nov; 6(11):959-77. PubMed ID: 18992037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New histopathologic findings in drug eruptions.
    Fitzpatrick JE
    Dermatol Clin; 1992 Jan; 10(1):19-36. PubMed ID: 1530913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mucositis].
    Sato A; Sakashita A; Taguchi S
    Nihon Rinsho; 2003 Jun; 61(6):959-65. PubMed ID: 12806943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatologic manifestations of cytotoxic therapy.
    Huang V; Anadkat M
    Dermatol Ther; 2011; 24(4):401-10. PubMed ID: 21910798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.
    Scheinfeld N
    J Drugs Dermatol; 2006 Mar; 5(3):228-31. PubMed ID: 16573254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
    Risum S; Langer SW
    Ugeskr Laeger; 2003 Aug; 165(33):3161-2. PubMed ID: 12968412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical toxicity of chemotherapeutic agents: dermatologic toxicity.
    Dunagin WG
    Semin Oncol; 1982 Mar; 9(1):14-22. PubMed ID: 6461923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.